$675.79
-18.85-2.71%
At close: -
$675.00
-0.79-0.12%
After Hours: Jan 24, 7:59 PM EDT
Comments
Loading...
Regeneron Pharmaceuticals (NASDAQ:REGN) Stock, Earnings Estimates, EPS, And Revenue
Regeneron Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Feb 4
EPS Estimate
$11.190
Quarterly Revenue Estimate
$3.76B
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$13.85B
Analyze the earnings history of Regeneron Pharmaceuticals using advanced sorting and filters.
Data brought to you by Benzinga APIs
Regeneron Pharmaceuticals (REGN) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-10-31 | $12.46 | $11.69 | 6.59 % |
| Q2 | 2024-08-01 | $11.56 | $10.53 | 9.78 % |
| Q1 | 2024-05-02 | $9.55 | $10.10 | -5.45 % |
| Q4 | 2024-02-02 | $11.86 | $10.77 | 10.1 % |
Regeneron Pharmaceuticals (REGN) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-10-31 | $3.72B | $3.67B | 1.39 % |
| Q2 | 2024-08-01 | $3.55B | $3.36B | 5.57 % |
| Q1 | 2024-05-02 | $3.15B | $3.22B | -2.33 % |
| Q4 | 2024-02-02 | $3.43B | $3.29B | 4.38 % |
FAQ
When is Regeneron Pharmaceuticals (NASDAQ:REGN) reporting earnings?
Regeneron Pharmaceuticals (REGN) is scheduled to report earnings on February 4, 2025. The last reported earnings were for reported on October 31, 2024 for Q3.
What were the latest earnings per share (EPS) for Regeneron Pharmaceuticals (NASDAQ:REGN)?
The Actual EPS was $12.46, which beat the estimate of $11.69.
What were Regeneron Pharmaceuticals’s (NASDAQ:REGN) revenues?
The Actual Revenue was $3.7B, which beat the estimate of $3.7B.
Browse earnings estimates, EPS, and revenue on all stocks.